ESR1 and invasive breast carcinoma: Atypical ductal hyperplasia (ADH) belongs to the low-grade pathway of estrogen receptor (ER)-positive/luminal type invasive breast carcinoma (iBC) [1], and it is one of the earliest steps in this pathway [2].